Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 7, 2017; 23(1): 87-92
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.87
Figure 3
Figure 3 Representative of the degree of gastric mucosal damage in the NaHS group (A) and the glibenclamide + NaHS group (B).